EQA Scheme
Contact
Mycobacterial Diagnostics - Drug Susceptibility Testing of Mycobacterium tuberculosis (425)
Samples:
5 samples of 1 mL
Sample properties:
Mycobacterium tuberculosis complex suspensions for phenotypic resistance testing (incl. second-line drugs)
Additional Information:
Note: EQA scheme containing infectious substances according to UN2814, infectious substances category A.
Each registration for this group must confirm that the test is performed in a laboratory with security level S3 and with appropriately qualified personnel.
Requirement for EQAS/PT according to Rili-BÄK
Parameters:
Susceptibility Testing of Tuberculosis Bacteria
Certificate Validity: 12 months
Not subject to Rili-BÄK
Parameters:
not applicable
Certificate Validity: not applicable
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material. The participating laboratory must be authorized to perform direct and/or indirect detection of pathogens.
Dates:
Registration deadline:
Sample shipment:
Closing Date:
| May (2) | Nov. (5) |
|---|---|
| 15.01.2027 | 09.07.2027 |
| 16.03.2027 | 07.09.2027 |
| 28.05.2027 | 19.11.2027 |
EQAS/PT Experts:
Dr. Sönke Andres
Forschungszentrum Borstel
Nationales Referenzzentrum für Mykobakterien
Parkallee 38
23845 Borstel
+49 4537 188 6480
sandres@fz-borstel.de